Gilead Sciences (GILD, +2.2%) once again helped inject a little life into stocks Friday with the help of its coronavirus treatment remdesivir. The major indices appeared poised for losses in early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback